Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

Task Force on PD Subtypes

Connie Marras, MD, PhD
Connie Marras
Tiago Mestre
Tiago Mestre

Task Force Mandate:

Understanding heterogeneity in Parkinson’s disease (PD) has deserved considerable attention for its recognized potential to elucidate the disease pathophysiology, its natural history, and namely for therapeutic development.  However, this body of research has not yet had a significant impact on our understanding or treatment of PD.

The Task Force for PD Subtypes will critically appraise the available evidence on PD subtyping, to provide an updated guidance for the design and conduct of future studies on PD subtypes. 

Task Force Aims:

1. To provide a portrait of current knowledge on PD subtypes

2. To provide a definition of PD subtypes and PD subtype classification system 

3. To develop a guidance document on the definition of PD subtypes and PD subtype classification systems and recommendations for next steps in research
 

At the completion of the Task Force program, we hope to have laid the foundations for future studies of higher methodological quality and more direct relevance for the field with a direct application in PD, but with a potential utility in other complex neurodegenerative conditions. 

 

MDS Staff Liaison: Annamarie Lofald

Task Force Members

Daniela Berg
Nicolaas Bohnen
Kathy Dujardin
Roberto Erro
Alberto Espay
Seyed-Mohammad Fereshtehnejad
Glenda Halliday

Michele Hu
Beomseok Jeon
Michael Lawton
Albert Leentjens
Michael McDermott
Brit Mollenhauer
Ron Postuma

Mayela Rodriguez Violante
Tatyana Simuni
D. James Surmeier
Daniel Weintraub
J.J. (Bob) Van Hilten

 

Resource Type

Please wait while we gather your results.

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice